BHARATEQUITY
Loading…
Pricing

Free data. Premium research. Simple pricing.

Standard market data, screener, and quality scorecards are free. The paid tier unlocks the full forensic research suite.

Free
₹0forever

All public data — better organised than anywhere else.

  • 10-year financials (P&L, Balance Sheet, Cash Flow)
  • Concall transcripts + annual report links
  • Stock screener · 4,500+ NSE & BSE with 30+ filter metrics
  • Price charts + technicals (RSI, MACD, moving averages)
  • News feed + corporate actions (dividends, splits)
  • Peer-relative valuation grid
  • Watchlist + portfolio tracker
  • Quality Scorecard + growth snapshot with CAGR trends
  • Industry Median Comparison · 14-metric stock-vs-sector benchmark
  • Macro dashboard (FX, commodities, rates)
  • Earnings calendar
  • Dixon full-feature demo — see every paid feature live, no signup
  • No credit card required
Sign up free
Most popular
Subscription
₹1,799/ month

or ₹17,999/year · save ₹3,589 (17%)

What's included every month:
  • · Unlimited views of every stock's full forensic report
  • · 4 brand-new stock extractions per forensic feature (most users use 1-3)
  • · 30 Ask Manthaan questions
  • · Need more? Deep Dive Packs from ₹499
Everything in Free, plus:
🛡️ Catch frauds before headlines do
Indian-listed companies file detailed disclosures every year — auditor's remarks, related-party transactions, contingent liabilities, governance reports. Most red flags show up there first. We read those filings for you and surface the warning signs.
  • Auditor's secret remarks (CARO) — every red flag the auditor noted, with the exact quote and page number
  • 3-year auditor trend — spots if concerns are escalating, plus auditor changes (often a red flag itself)
  • Related-party deals — every transaction with promoter family, subsidiaries, JVs; flags loans to promoter entities (the #1 fraud pattern)
  • Hidden liabilities — tax disputes, lawsuits, guarantees not on the balance sheet but disclosed in footnotes
  • Earnings quality score — 11 academic models (Beneish, Piotroski, Altman, etc.) flagging suspicious accounting
  • Plain-English forensic verdict — synthesises everything above into 3 sentences you can act on
🏛️ See how the company is actually run
Board independence, who pays whom, who audits the books, any SEBI penalties — the governance picture most retail investors never see.
  • Governance Card — board independence ratio, Chairman/CEO separation, every director's pay vs net profit, statutory auditor with any qualifications, SEBI/exchange penalties
  • Promoter risk scorecard — pledge severity, insider trades, AGM outcomes, recent SAST disclosures
  • Business segments breakdown — actual revenue split by business + geography (extracted from the AR, not just management commentary)
📊 Research tools that save you hours
The deep-dive analysis that takes a buy-side analyst 4 hours per stock — done for you in seconds.
  • Working capital deep-dive — receivables/inventory/payables trends, cash conversion cycle
  • Capital allocation analysis — multi-year view of where management put the cash
  • Capital allocation score — ROCE consistency, FCF generation, leverage discipline, dilution
  • Quality decay watch — early-warning system for ROCE compression, margin trends, leverage changes
  • Macro sensitivity — how this stock moves with Nifty, USD/INR, oil, gold
  • News impact tracker — price reaction to news events adjusted for Nifty
💬 Ask any question, get an answer
Manthaan has already read all the research above — chat with it like an analyst.
  • 30 questions per month included — examples: "Is this stock cheap historically?", "What's the biggest risk?", "Compare ROCE to peers"
  • Extra question packs available (₹150-₹1,200) if you use more
🎯 Portfolio + watchlist tools
Manage your holdings like a small-cap institutional fund.
  • Watchlist forensic radar — your watchlist sorted by red-flag count
  • Portfolio tracker with sector breakdown and P&L
  • Price alerts
  • Compare stocks side-by-side with forensic signals
You'll be asked to sign in first.
Need more in a month?

Deep Dive Packs

Packs add extra extractions for the current month and apply to all 5 forensic features at once (CARO, RPT, Contingent Liabilities, Governance, Segments).

Deep Dive Pack
499
+1 fresh extraction for each forensic feature this month
Deep Dive Pack ×3
Save 13%
1,299
+3 fresh extractions for each forensic feature this month
Deep Dive Pack ×10
Save 20%
3,999
+10 fresh extractions for each forensic feature this month

Pack extras expire at month-end. Available only to active subscribers.

Bharat Equity is for you if you…
  • Read annual reports (or want to but don't have 4 hours per stock)
  • Hold stocks for years, not weeks — quality investing, not trading
  • Want to spot governance / fraud signals BEFORE they hit headlines
  • Have a research process — concentrated portfolio of 10-25 names
  • Recognize names like Beneish, Altman, Piotroski (or are willing to learn)
Not the right fit if you…
  • Are a day trader or momentum chaser — most active-trading platforms suit you better
  • Want ready-made stock tips or curated portfolios — consult a SEBI RA-registered advisor
  • Just need a watchlist + price alerts — your broker app already does this
  • Trade more than you research — this won't move your needle
  • Want technical analysis / charting tools — dedicated charting platforms fit better
What you get for ₹1,799/month

Analyst-grade forensic research, surfaced from filings most retail never opens.

~₹60/day
Analyst-grade forensic depth at a retail price.
11 academic models
Beneish, Sloan, Altman Z, Piotroski F, Novy-Marx, Dechow F, plus stability / persistence / accruals / asset-growth — applied per stock, surfaced in plain English.
6 forensic engines
CARO · RPT · Contingent Liabilities · Governance Card · Auditor Worry Score · Earnings Quality — verbatim quotes with page citations.

Every flag is sourced from the company's own filings (annual reports, concall transcripts, BSE/NSE disclosures). Signals are surfaced and synthesised for your own analysis. This is research output, not investment advice; for buy/sell decisions, consult a SEBI-registered investment advisor.

See a live sample (Dixon) →Full forensic + governance + research suite on Dixon Technologies — no signup needed.
A note on what this is
Bharat Equity provides structured data, analytical tools, and research summaries on Indian-listed companies. It does not provide buy/sell/hold recommendations, execute trades, or manage portfolios. All output is research and analytical information for your own analysis. For investment decisions, consult a SEBI-registered investment advisor.